{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:57Z","timestamp":1793226837858,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science and Technology Major Project of China under Grant","award":["# 2018ZX10302-206-003-006"],"award-info":[{"award-number":["# 2018ZX10302-206-003-006"]}]},{"name":"Capital's Funds for Health Improvement and Research","award":["# CFH 2020-1-2171"],"award-info":[{"award-number":["# CFH 2020-1-2171"]}]},{"name":"Beijing Hospitals Authority Clinical Medicine Development of Special Funding","award":["# XMLX201837"],"award-info":[{"award-number":["# XMLX201837"]}]},{"DOI":"10.13039\/501100015850","name":"the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority","doi-asserted-by":"crossref","award":["# XXT26"],"award-info":[{"award-number":["# XXT26"]}],"id":[{"id":"10.13039\/501100015850","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12072-021-10230-6","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T11:19:30Z","timestamp":1633087170000},"page":"1053-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection"],"prefix":"10.1007","volume":"15","author":[{"given":"Xiu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-6688","authenticated-orcid":false,"given":"Calvin Q.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-9669","authenticated-orcid":false,"given":"Huichun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"10230_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fcimb.2019.00377","volume":"9","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Xia P, Zhou X, et al. Hepatitis B virus infection alters gut microbiota composition in mice. Front Cell Infect Microbiol 2019;9:377","journal-title":"Front Cell Infect Microbiol"},{"key":"10230_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13099-020-00391-4","volume":"12","author":"XA Yang","year":"2020","unstructured":"Yang XA, Lv F, Wang R, et al. Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B. Gut Pathog 2020;12:50","journal-title":"Gut Pathog"},{"key":"10230_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fmicb.2020.00383","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xie Y, Zhou F, et al. Featured gut microbiomes associated with the progression of chronic hepatitis B disease. Front Microbiol 2020;11:383","journal-title":"Front Microbiol"},{"issue":"7","key":"10230_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","volume":"26","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A, Wilmes P. Human gut microbiome: function matters. Trends Microbiol 2018;26(7):563\u2013574","journal-title":"Trends Microbiol"},{"key":"10230_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mib.2016.10.003","volume":"35","author":"M Levy","year":"2017","unstructured":"Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol 2017;35:8\u201315","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"10230_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016;16(6):341\u2013352","journal-title":"Nat Rev Immunol"},{"issue":"6086","key":"10230_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012;336(6086):1262\u20131267","journal-title":"Science"},{"issue":"3","key":"10230_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","volume":"61","author":"H Lu","year":"2011","unstructured":"Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol 2011;61(3):693\u2013703","journal-title":"Microb Ecol"},{"key":"10230_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1550","author":"A Mohamadkhani","year":"2018","unstructured":"Mohamadkhani A. On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B. Cancer Med 2018. https:\/\/doi.org\/10.1002\/cam4.1550","journal-title":"Cancer Med."},{"issue":"2","key":"10230_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jvh.13216","volume":"27","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Chen S, Fu Y, et al. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Viral Hepat 2020;27(2):143\u2013155","journal-title":"J Viral Hepat"},{"issue":"6246","key":"10230_CR11","doi-asserted-by":"publisher","first-page":"1254766","DOI":"10.1126\/science.1254766","volume":"349","author":"MS Donia","year":"2015","unstructured":"Donia MS, Fischbach MA. Small molecules from the human microbiota. Science 2015;349(6246):1254766","journal-title":"Science."},{"key":"10230_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0704-8","author":"O Kaitlyn","year":"2019","unstructured":"Kaitlyn O, Emma A. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome 2019. https:\/\/doi.org\/10.1186\/s40168-019-0704-8","journal-title":"Microbiome."},{"issue":"6","key":"10230_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165(6):1332\u20131345","journal-title":"Cell"},{"key":"10230_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","volume":"1","author":"D Patrice","year":"2019","unstructured":"Patrice D, Cani MH, Charlotte Lefort C, Marialetizia RA. Microbial regulation of organismal energy. Nat Metab 2019;1:34\u201346","journal-title":"Nat Metab"},{"issue":"4","key":"10230_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4162\/nrp.2015.9.4.343","volume":"9","author":"TH Jung","year":"2015","unstructured":"Jung TH, Park JH, Jeon WM, Han KS. Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway. Nutr Res Pract 2015;9(4):343\u2013349","journal-title":"Nutr Res Pract"},{"issue":"9","key":"10230_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009;139(9):1619\u20131625","journal-title":"J Nutr"},{"issue":"2","key":"10230_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 2019;50(2):432-445.e7","journal-title":"Immunity"},{"key":"10230_CR18","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3389\/fimmu.2018.02838","volume":"9","author":"C Martin-Gallausiaux","year":"2018","unstructured":"Martin-Gallausiaux C, Larraufie P, Jarry A, et al. Butyrate produced by commensal bacteria down-regulates indolamine 2,3-dioxygenase 1 (IDO-1) expression via a dual mechanism in human intestinal epithelial cells. Front Immunol 2018;9:2838","journal-title":"Front Immunol"},{"issue":"6","key":"10230_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 2019;68(6):1014\u20131023","journal-title":"Gut"},{"key":"10230_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","volume":"12","author":"K Pant","year":"2017","unstructured":"Pant K, Yadav AK, Gupta P, Islam R, Saraya A, Venugopal SK. Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells. Redox Biol 2017;12:340\u2013349","journal-title":"Redox Biol"},{"issue":"1","key":"10230_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T, et al. Butyrate: a double-edged sword for health. Adv Nutr 2018;9(1):21\u201329","journal-title":"Adv Nutr"},{"issue":"4","key":"10230_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/mc.22946","volume":"58","author":"K Pant","year":"2019","unstructured":"Pant K, Mishra AK, Pradhan SM, et al. Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1\/Ac-p53 regulatory axis. Mol Carcinog 2019;58(4):524\u2013532","journal-title":"Mol Carcinog"},{"key":"10230_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2019.1674124","author":"A Jenessa","year":"2019","unstructured":"Jenessa A, Winston CMT. Diversification of host bile acids by members of the gut microbiota. Gut Microbes 2019. https:\/\/doi.org\/10.1080\/19490976.2019.1674124","journal-title":"Gut Microbes"},{"key":"10230_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1127483","author":"M Ridlon Jason","year":"2016","unstructured":"Ridlon Jason M, Harris Spencer C, Shiva B, Dae-Joong K, Hylemon Phillip B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016. https:\/\/doi.org\/10.1080\/19490976.2015.1127483","journal-title":"Gut Microbes"},{"issue":"41","key":"10230_CR25","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.3748\/wjg.v21.i41.11597","volume":"21","author":"U Makoto","year":"2015","unstructured":"Makoto U, Makoto M, Hayato Y. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015;21(41):11597\u201311608","journal-title":"World J Gastroenterol"},{"key":"10230_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2017.06.002","author":"L Long Sarah","year":"2017","unstructured":"Long Sarah L, Gahan Cormac GM, Joyce Susan A. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med 2017. https:\/\/doi.org\/10.1016\/j.mam.2017.06.002","journal-title":"Mol Aspects Med"},{"key":"10230_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2018.04.028","author":"H Mullish Benjamin","year":"2018","unstructured":"Mullish Benjamin H, Alexandros P, Barker Grace F, Thursz Mark R, Marchesi Julian R, McDonald Julie AK. Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease. Methods 2018. https:\/\/doi.org\/10.1016\/j.ymeth.2018.04.028","journal-title":"Methods"},{"issue":"2","key":"10230_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17(2):225\u2013235","journal-title":"Cell Metab"},{"issue":"10","key":"10230_CR29","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","volume":"103","author":"T Inagaki","year":"2006","unstructured":"Inagaki T, Moschetta A, Lee YK, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA 2006;103(10):3920\u20133925","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10230_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.dld.2013.01.001","volume":"45","author":"HJ Huang","year":"2013","unstructured":"Huang HJ, Zhang AY, Cao HC, et al. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. Dig Liver Dis 2013;45(8):677\u2013682","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10230_CR31","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1111\/jcmm.14951","volume":"24","author":"X Wang","year":"2020","unstructured":"Wang X, Chen L, Wang H, Cai W, Xie Q. Modulation of bile acid profile by gut microbiota in chronic hepatitis B. J Cell Mol Med 2020;24(4):2573\u20132581","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10230_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1053\/jhep.2003.50116","volume":"37","author":"V Lorenzo-Z\u00fa\u00f1iga","year":"2003","unstructured":"Lorenzo-Z\u00fa\u00f1iga V, Bartol\u00ed R, Planas R, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 2003;37(3):551\u2013557","journal-title":"Hepatology"},{"issue":"4","key":"10230_CR33","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/acs.jproteome.5b00217","volume":"15","author":"X Wang","year":"2016","unstructured":"Wang X, Xie G, Zhao A, et al. Serum bile acids are associated with pathological progression of hepatitis B-induced cirrhosis. J Proteome Res 2016;15(4):1126\u20131134","journal-title":"J Proteome Res"},{"issue":"10","key":"10230_CR34","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1002\/ijc.33051","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick JL, Florio AA, Koshiol J, et al. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies. Int J Cancer 2020;147(10):2743\u20132753","journal-title":"Int J Cancer"},{"issue":"7456","key":"10230_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013;499(7456):97\u2013101","journal-title":"Nature"},{"issue":"2","key":"10230_CR36","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1096\/fj.201801181R","volume":"33","author":"K Mouzannar","year":"2019","unstructured":"Mouzannar K, Fusil F, Lacombe B, et al. Farnesoid X receptor-\u03b1 is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo. FASEB J 2019;33(2):2472\u20132483","journal-title":"FASEB J"},{"key":"10230_CR37","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1:e00049. https:\/\/doi.org\/10.7554\/eLife.00049","journal-title":"eLife"},{"issue":"4","key":"10230_CR38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jhep.2014.05.018","volume":"61","author":"A K\u00f6nig","year":"2014","unstructured":"K\u00f6nig A, D\u00f6ring B, Mohr C, Geipel A, Geyer J, Glebe D. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+\/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. J Hepatol 2014;61(4):867\u2013875","journal-title":"J Hepatol"},{"issue":"6","key":"10230_CR39","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1128\/JVI.03478-13","volume":"88","author":"H Yan","year":"2014","unstructured":"Yan H, Peng B, Liu Y, et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol 2014;88(6):3273\u20133284","journal-title":"J Virol"},{"issue":"5","key":"10230_CR40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.27159","volume":"60","author":"N Oehler","year":"2014","unstructured":"Oehler N, Volz T, Bhadra OD, et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 2014;60(5):1483\u20131493","journal-title":"Hepatology"},{"issue":"9","key":"10230_CR41","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1096\/fj.201500134","volume":"30","author":"P Radreau","year":"2016","unstructured":"Radreau P, Porcherot M, Rami\u00e8re C, Mouzannar K, Lotteau V, Andr\u00e9 P. Reciprocal regulation of farnesoid X receptor \u03b1 activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes. FASEB J 2016;30(9):3146\u20133154","journal-title":"FASEB J"},{"key":"10230_CR42","unstructured":"Robin E PA, Elise R NB, Hugo G RD, Jacky V. Safety and antiviral effect of the farnesoid X receptor agonist EYP001 in chronic hepatitis B patients: a randomised placebo-controlled phase 1b study. Ameican Association for the study of Liver Diseases Abstracts 709, 2019."},{"issue":"1","key":"10230_CR43","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun 2018;9(1):3294","journal-title":"Nat Commun"},{"issue":"6","key":"10230_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 2018;23(6):716\u2013724","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10230_CR45","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/JVI.01998-10","volume":"85","author":"R Mao","year":"2011","unstructured":"Mao R, Zhang J, Jiang D, et al. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 2011;85(2):1048\u20131057","journal-title":"J Virol"},{"issue":"1","key":"10230_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/hep.28282","volume":"63","author":"S Yoshio","year":"2016","unstructured":"Yoshio S, Sugiyama M, Shoji H, et al. Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. Hepatology 2016;63(1):83\u201394","journal-title":"Hepatology"},{"key":"10230_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/IJTR.S26862","volume":"8","author":"V Mehraj","year":"2015","unstructured":"Mehraj V, Routy JP. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int J Tryptophan Res 2015;8:41\u201348","journal-title":"Int J Tryptophan Res"},{"issue":"2","key":"10230_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013;39(2):372\u2013385","journal-title":"Immunity"},{"issue":"6","key":"10230_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016;22(6):598\u2013605","journal-title":"Nat Med"},{"issue":"1","key":"10230_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.0906112107","volume":"107","author":"T Bansal","year":"2010","unstructured":"Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 2010;107(1):228\u2013233","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10230_CR51","doi-asserted-by":"publisher","first-page":"e80604","DOI":"10.1371\/journal.pone.0080604","volume":"8","author":"Y Shimada","year":"2013","unstructured":"Shimada Y, Kinoshita M, Harada K, et al. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One 2013;8(11):e80604","journal-title":"PLoS One."},{"key":"10230_CR52","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1096\/fj.201800544","volume":"32","author":"M Beaumont","year":"2018","unstructured":"Beaumont M, Neyrinck AM, Olivares M, et al. The gut microbiota metabolite indole alleviates liver inflammation in mice. FASEB J 2018;32:6681\u20136693","journal-title":"FASEB J"},{"issue":"4","key":"10230_CR53","doi-asserted-by":"publisher","first-page":"R646","DOI":"10.1152\/ajpregu.00111.2018","volume":"315","author":"T Huc","year":"2018","unstructured":"Huc T, Konop M, Onyszkiewicz M, et al. Colonic indole, gut bacteria metabolite of tryptophan, increases portal blood pressure in rats. Am J Physiol Regul Integr Comp Physiol 2018;315(4):R646\u2013R655","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10230_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao J, Xu K, Liu H, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol 2018;8:13","journal-title":"Front Cell Infect Microbiol"},{"key":"10230_CR55","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res 2017;10:1178646917691938","journal-title":"Int J Tryptophan Res"},{"key":"10230_CR56","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3389\/fimmu.2017.01374","volume":"8","author":"AP Van der Leek","year":"2017","unstructured":"Van der Leek AP, Yanishevsky Y, Kozyrskyj AL. The kynurenine pathway as a novel link between allergy and the gut microbiome. Front Immunol 2017;8:1374","journal-title":"Front Immunol"},{"issue":"6","key":"10230_CR57","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2012.77","volume":"18","author":"G Clarke","year":"2013","unstructured":"Clarke G, Grenham S, Scully P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013;18(6):666\u2013673","journal-title":"Mol Psychiatry"},{"key":"10230_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2015.04.004","volume":"48","author":"L Desbonnet","year":"2015","unstructured":"Desbonnet L, Clarke G, Traplin A, et al. Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav Immun 2015;48:165\u2013173","journal-title":"Brain Behav Immun"},{"issue":"Pt B","key":"10230_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 2017;112(Pt B):399\u2013412","journal-title":"Neuropharmacology"},{"issue":"2","key":"10230_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015;161(2):264\u2013276","journal-title":"Cell"},{"issue":"4","key":"10230_CR61","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jcmgh.2019.01.004","volume":"7","author":"YH Kwon","year":"2019","unstructured":"Kwon YH, Wang H, Denou E, et al. Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis. Cell Mol Gastroenterol Hepatol 2019;7(4):709\u2013728","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"10230_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.surge.2011.11.002","volume":"10","author":"M Lesurtel","year":"2012","unstructured":"Lesurtel M, Soll C, Humar B, Clavien PA. Serotonin: a double-edged sword for the liver. Surgeon 2012;10(2):107\u2013113","journal-title":"Surgeon"},{"issue":"7","key":"10230_CR63","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nm1780","volume":"14","author":"PA Lang","year":"2008","unstructured":"Lang PA, Contaldo C, Georgiev P, et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 2008;14(7):756\u2013761","journal-title":"Nat Med"},{"key":"10230_CR64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/CMAR.S148097","volume":"9","author":"CM Chang","year":"2017","unstructured":"Chang CM, Hsieh MS, Yang TC, et al. Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients. Cancer Manag Res 2017;9:709\u2013720","journal-title":"Cancer Manag Res"},{"key":"10230_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103228","author":"M Canyelles","year":"2018","unstructured":"Canyelles M, Tondo M, Ced\u00f3 L, Farr\u00e0s M, Escol\u00e0-Gil JC, Blanco-Vaca F. Trimethylamine N-Oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. Int J Mol Sci 2018. https:\/\/doi.org\/10.3390\/ijms19103228","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10230_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41564-018-0294-4","volume":"4","author":"CL Chittim","year":"2019","unstructured":"Chittim CL, Mart\u00ednez Del Campo A, Balskus EP. Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline. Nat Microbiol 2019;4(1):155\u2013163","journal-title":"Nat Microbiol"},{"issue":"3","key":"10230_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.chom.2017.07.021","volume":"22","author":"KA Romano","year":"2017","unstructured":"Romano KA, Martinez-Del Campo A, Kasahara K, et al. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption. Cell Host Microbe 2017;22(3):279-290.e7","journal-title":"Cell Host Microbe"},{"issue":"16","key":"10230_CR68","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.3748\/wjg.v22.i16.4191","volume":"22","author":"IJ Cox","year":"2016","unstructured":"Cox IJ, Aliev AE, Crossey MM, et al. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: a biomarker corroboration study. World J Gastroenterol 2016;22(16):4191\u20134200","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10230_CR69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molmed.2019.11.005","volume":"26","author":"RE Steinert","year":"2020","unstructured":"Steinert RE, Lee YK, Sybesma W. Vitamins for the gut microbiome. Trends Mol Med 2020;26(2):137\u2013140","journal-title":"Trends Mol Med"},{"issue":"2","key":"10230_CR70","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","volume":"54","author":"MT Cantorna","year":"2019","unstructured":"Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Biochem Mol Biol 2019;54(2):184\u2013192","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10230_CR71","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fgene.2015.00148","volume":"6","author":"S Magn\u00fasd\u00f3ttir","year":"2015","unstructured":"Magn\u00fasd\u00f3ttir S, Ravcheev D, de Cr\u00e9cy-Lagard V, Thiele I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 2015;6:148","journal-title":"Front Genet"},{"issue":"4","key":"10230_CR72","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3945\/ajcn.117.155424","volume":"106","author":"JP Karl","year":"2017","unstructured":"Karl JP, Meydani M, Barnett JB, et al. Fecal concentrations of bacterially derived vitamin K forms are associated with gut microbiota composition but not plasma or fecal cytokine concentrations in healthy adults. Am J Clin Nutr 2017;106(4):1052\u20131061","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10230_CR73","doi-asserted-by":"publisher","first-page":"920","DOI":"10.5604\/01.3001.0012.7192","volume":"17","author":"AH Koop","year":"2018","unstructured":"Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An argument for vitamin D, A, and zinc monitoring in cirrhosis. Ann Hepatol 2018;17(6):920\u2013932","journal-title":"Ann Hepatol"},{"issue":"1","key":"10230_CR74","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12879-016-1836-0","volume":"16","author":"NX Hoan","year":"2016","unstructured":"Hoan NX, Khuyen N, Binh MT, et al. Association of vitamin D deficiency with hepatitis B virus\u2014related liver diseases. BMC Infect Dis 2016;16(1):507","journal-title":"BMC Infect Dis"},{"key":"10230_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2013.02.024","volume":"60","author":"X Shen","year":"2013","unstructured":"Shen X, Carlstr\u00f6m M, Borniquel S, J\u00e4dert C, Kevil CG, Lundberg JO. Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med 2013;60:195\u2013200","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10230_CR76","doi-asserted-by":"publisher","first-page":"G143","DOI":"10.1152\/ajpgi.00249.2017","volume":"314","author":"JL Wallace","year":"2018","unstructured":"Wallace JL, Motta JP, Buret AG. Hydrogen sulfide: an agent of stability at the microbiome-mucosa interface. Am J Physiol Gastrointest Liver Physiol 2018;314(2):G143\u2013G149","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"10230_CR77","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41575-019-0193-z","volume":"16","author":"K Kalantar-Zadeh","year":"2019","unstructured":"Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR. Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nat Rev Gastroenterol Hepatol 2019;16(12):733\u2013747","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10230_CR78","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fphys.2012.00448","volume":"3","author":"F Carbonero","year":"2012","unstructured":"Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol 2012;3:448","journal-title":"Front Physiol"},{"issue":"1","key":"10230_CR79","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MCO.0000000000000526","volume":"22","author":"F Blachier","year":"2019","unstructured":"Blachier F, Beaumont M, Kim E. Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care 2019;22(1):68\u201375","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10230_CR80","first-page":"3831713","volume":"2019","author":"DD Wu","year":"2019","unstructured":"Wu DD, Wang DY, Li HM, Guo JC, Duan SF, Ji XY. Hydrogen sulfide as a novel regulatory factor in liver health and disease. Oxid Med Cell Longev 2019;2019:3831713","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10230_CR81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3892\/mmr.2012.1153","volume":"7","author":"HN Fan","year":"2013","unstructured":"Fan HN, Wang HJ, Yang-Dan CR, et al. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells. Mol Med Rep 2013;7(1):247\u2013253","journal-title":"Mol Med Rep"},{"key":"10230_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1406726","author":"F Zhang","year":"2017","unstructured":"Zhang F, Jin H, Wu L, et al. Diallyl trisulfide suppresses oxidative stress-induced activation of hepatic stellate cells through production of hydrogen sulfide. Oxid Med Cell Longev 2017. https:\/\/doi.org\/10.1155\/2017\/1406726","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10230_CR83","first-page":"5022","volume":"14","author":"W Wei","year":"2017","unstructured":"Wei W, Wang C, Li D. The content of hydrogen sulfide in plasma of cirrhosis rats combined with portal hypertension and the correlation with indexes of liver function and liver fibrosis. Exp Ther Med 2017;14(5):5022\u20135026","journal-title":"Exp Ther Med"},{"issue":"9","key":"10230_CR84","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10620-017-4689-5","volume":"62","author":"LL Barton","year":"2017","unstructured":"Barton LL, Ritz NL, Fauque GD, Lin HC. Sulfur cycling and the intestinal microbiome. Dig Dis Sci 2017;62(9):2241\u20132257","journal-title":"Dig Dis Sci"},{"key":"10230_CR85","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3389\/fmicb.2017.02222","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Wang Y, Zhang X, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol 2017;8:2222","journal-title":"Front Microbiol"},{"issue":"5","key":"10230_CR86","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/hep.29008","volume":"65","author":"YD Ren","year":"2017","unstructured":"Ren YD, Ye ZS, Yang LZ, et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology 2017;65(5):1765\u20131768","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10230-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T16:27:47Z","timestamp":1634142467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10230"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10230-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xiu Sun, Cavin.Q.Pan and Huichun Xing declare that there is no conflict of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the version of the manuscript to be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}